BIIB Stock: Price, Earnings History and SEC Filings
Biogen Inc. (BIIB) last traded at $253.62, up 1.59% on the latest session and up 12.3% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $2.62 against an analyst estimate of $2.06, a beat of 27.2%.
$253.62 +1.59%
1 month+12.28%
52-week high$258.78
52-week low$148.51
Volume1.30M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
BIIB earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 28, 2026 | $2.62 | $2.06 | +27.18% |
| Jun 2026 | Jul 29, 2026 | $3.60 | $3.04 | +18.42% |
| Mar 2026 | Apr 29, 2026 | $3.57 | $2.95 | +21.02% |
| Dec 2025 | Feb 6, 2026 | $1.99 | $1.61 | +23.60% |
BIIB beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for BIIB
SEC filing data is not available right now. You can search for BIIB on SEC EDGAR.
BIIB news
- What Just Happened To Alnylam Stock?Oct 30, 2026 · trefis.com
- Biogen Swings Back to Growth as Stock Momentum Could Continue, RBC SaysOct 29, 2026 · finance.yahoo.com
- Alphabet downgraded, eBay upgraded: Wall Street's top analyst callsOct 29, 2026 · finance.yahoo.com
- Biogen to Present New Data Across Alzheimer's Disease Portfolio at CTAD 2026Oct 29, 2026 · finance.yahoo.com
- What to expect from Regeneron’s (REGN) Q3 earningsOct 29, 2026 · finance.yahoo.com
- Biogen (BIIB) Stock Price Tracks Q3 Results Through Loss And Cash FlowOct 29, 2026 · finance.yahoo.com
- Biogen Q3 Earnings Call HighlightsOct 28, 2026 · marketbeat.com
- Biogen Has 'Returned To Growth,' Says CEO — What To Know About Its ReportOct 28, 2026 · finance.yahoo.com
About Biogen Inc.
Biogen Inc. (BIIB) is a US-listed public company on Nasdaq.